Literature DB >> 8290098

Cognitive deficits of men and women with Alzheimer's disease.

V W Henderson1, J G Buckwalter.   

Abstract

We performed two studies of cognitive abilities among men and women who met clinical criteria for Alzheimer's disease (AD). Among 46 AD patients, performance of women on a composite neuropsychological battery was more impaired than that of men when the potentially confounding effects of demographic variables were controlled; the largest group differences were due to significantly worse performance by women with AD on a naming task. Based on these initial findings, we next analyzed an independent data set of 647 demented subjects enrolled in the multicenter Consortium to Establish a Registry for Alzheimer's Disease, hypothesizing that the naming performance of women with AD would be significantly worse than that of men with this illness. Analyses controlling for demographic variables, or separately controlling for dementia severity, confirmed that women with AD performed significantly less well on the naming task and on verbal fluency. Women also performed less well on delayed recall, but there were no significant differences on other tasks. Factor analysis confirmed significant differences on a language factor, implying that men retain verbal skills better than women do during the initial stages of AD. Elderly nondemented women performed as well as or better than nondemented men on all comparisons. We conclude that there are modest differences in how men and women with AD perform on cognitive tasks and that differences may be discrete rather than global in nature.

Entities:  

Mesh:

Year:  1994        PMID: 8290098     DOI: 10.1212/wnl.44.1.90

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  46 in total

Review 1.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

Review 2.  Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.

Authors:  P M Maki; V W Henderson
Journal:  Climacteric       Date:  2012-06       Impact factor: 3.005

3.  Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.

Authors:  Kun Don Yi; James W Simpkins
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

4.  Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI.

Authors:  Martha Skup; Hongtu Zhu; Yaping Wang; Kelly S Giovanello; Ja-an Lin; Dinggang Shen; Feng Shi; Wei Gao; Weili Lin; Yong Fan; Heping Zhang
Journal:  Neuroimage       Date:  2011-02-26       Impact factor: 6.556

Review 5.  Strategies for Preventing Cognitive Decline in Healthy Older Adults.

Authors:  Julie A Dumas
Journal:  Can J Psychiatry       Date:  2017-07-13       Impact factor: 4.356

Review 6.  Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?

Authors:  Lay Kodama; Li Gan
Journal:  Trends Mol Med       Date:  2019-06-03       Impact factor: 11.951

Review 7.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

Review 8.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

9.  Gender-specificities in Alzheimer's disease and mild cognitive impairment.

Authors:  U Beinhoff; H Tumani; J Brettschneider; D Bittner; M W Riepe
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

Review 10.  Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.

Authors:  Chun Shi; Jun Liu; Fengming Wu; David T Yew
Journal:  Int J Mol Sci       Date:  2010-01-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.